Recently, Kim et al. [57] proposed a novel intracellular mechanism by which IL-33 might induce cell proliferation in breast tumor cells based on studies showing that administration of IL-33 increased the phosphorylation of Cancer Osaka Thyroid (COT) protein via a dose- and time-dependent interaction between ST2 and COT. This evidence concerns the gene IL33 and breast neoplasm.